Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Methicillin-Resistant Staphylococcus aureus (MRSA)

During the past four decades, methicillin-resistant Staphylococcus aureus, or MRSA, has evolved from a controllable nuisance into a serious public health concern. MRSA is largely a hospital-acquired infection, in fact, one of the most common. Recently, however, new strains have emerged in the community that are capable of causing severe infections in otherwise healthy people.

Featured Research

NIH-Backed Vaccine Shows Promise Against Common Healthcare-Associated Infections

NIH Grantees Find Genes for Susceptibility to MRSA Bacteria in Mice

MRSA Proves a Stubborn Opponent in Labs and Locker Rooms

NIAID-Funded Researchers Discover An Additional Way that S. Aureus Evades Immune System Attacks

What's New

Media Availability: Researchers Launch Phase 1 Clinical Trial of Potential MRSA Treatment—Jan. 24, 2014

Media Availability: NIH-Supported Clinical Trial of Novel Staphylococcal Antibiotic Begins—Oct. 17, 2012

Media Availability: NIH Scientists Link Quickly Spreading Gene to Asian MRSA Epidemic—April 22, 2012

Media Availability: NIH-Supported Scientists Investigate a Newly Emerging Staph Strain—Feb. 28, 2012

News From NIAID-Supported Institutions


Last Updated June 22, 2015